Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia

H. von Goessel, U. Jacobs, S. Semper, M. Krumbholz, T. Langer, T. Keller, A. Schrauder, V. H.J. van der Velden, J. J.M. van Dongen, J. Harbott, E. R. Panzer-Grümayer, M. Schrappe, W. Rascher, M. Metzler*

*Korrespondierende/r Autor/-in für diese Arbeit
16 Zitate (Scopus)

Abstract

Fusion between ETV6 and RUNX1 defines the largest genetic subgroup in childhood ALL. The genomic fusion site, unique to individual patients and specific for the malignant clone, represents an ideal molecular marker for quantification of minimal residual disease. Sequencing of DNA breakpoints has been difficult due to the extended size of the respective breakpoint cluster regions. We therefore evaluated a specially designed multiplex long-range PCR assay in 65 diagnostic bone marrow samples for its suitability in routine use. Resulting fusion sites and breakpoints derived from previous studies were subject to cluster analysis to identify potential sequence motifs involved in translocation initiation.

OriginalspracheEnglisch
ZeitschriftLeukemia Research
Jahrgang33
Ausgabenummer8
Seiten (von - bis)1082-1088
Seitenumfang7
ISSN0145-2126
DOIs
PublikationsstatusVeröffentlicht - 08.2009

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren